BUSINESS

More news
ImmunityBio

ImmunityBio (IBRX) Stock Explodes 500%+ in 2026 on ANKTIVA's 700% Revenue Surge

ImmunityBio Inc.'s stock has skyrocketed in early 2026, surging more than 500% year-to-date and hitting new 52-week highs above $11 as explosive sales growth for its flagship immunotherapy ANKTIVA, coupled with rapid international regulatory approvals and partnerships, fuels investor enthusiasm for the cancer-focused biotech.
WhipSmart

The Business Case for EVs Is Taking Off – Here's What's Driving It

While much of the public discourse focuses on passenger cars, a quiet revolution is also currently underway in the commercial sector. This development signal is clear: the country's logistics backbone is preparing for an electrified future.
Where U?

Why Are Australian Business Owners Choosing Workshops Over Marketing Agencies?

Across Australia, more business owners are rethinking a decision to outsource customer acquisition to a marketing agency. One example is "Where U?," a two-day in-person workshop designed to teach Australian business owners how to generate leads using Meta and Google Ads, framed less as a "marketing hack" and more as a repeatable engine.

Pages

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next